Breaking News

You are here » Indian-Commodity  :  Corporate  :  Mangalam Drugs receives final approval from WHO for Emtricitabine

16-Sep2017

Mangalam Drugs receives final approval from WHO for Emtricitabine

Mangalam Drugs & Organics has recently received the final approval from WHO for the drug Emtricitabine. Earlier in May, the company had received the final approval from WHO-Geneva for its plant at Unit-2 situated at G.I.D.C, Vapi, in the state of Gujarat.

Mangalam Drugs & Organics is a part of the MangalamGroup, manufactures chemicals such as API perfumery, disperse dye intermediates, bulk drugs and bulk drugs intermediates at VAPI-Gujarat State. It has a multi-product manufacturing facility and a in-house Research and Development (R&D) Base.



Related News

View all news

Monnet Ispat and Energy's net loss widens to Rs 2,860 crore in Q2

Monnet Ispat and Energy has reported results for second quarter ended September 30, 2018.The company has reported net loss of Rs 2,859.56 crore for the quarter under review as compared to the net loss......

Trident reports 25% revenue growth in textile segment

Trident has reported 24.6% Y-o-Y revenue growth in textile segment at Rs 1143.3 crore in Q2 FY19 as against Rs 917.2 crore in Q2 FY 18), while Paper & Chemicals segment revenue stood at Rs 248.4......

Delta Corp reports 11% rise in Q2 consolidated net profit

Delta Corp has reported results for second quarter ended September 30, 2018.The company has reported over 2-fold jump in its net profit at Rs 63.51 crore for the quarter under review as compared to Rs......

Top News

View all news

Shalimar Paints lays down foundation of Nashik manufacturing plant

Shalimar Paints has laid down the foundation of a manufacturing unit to be rebuilt in Nashik, in the state of Maharashtra. The company set to commence operations by April 2019 with a planned production......

Delta Corp reports 11% rise in Q2 consolidated net profit

Delta Corp has reported results for second quarter ended September 30, 2018.The company has reported over 2-fold jump in its net profit at Rs 63.51 crore for the quarter under review as compared to Rs......

PNB plans to sell non-core assets worth Rs 8,600 crore during FY19

Punjab National Bank (PNB) has recognized various assets, including its housing finance arm, for sale and hopes to realise Rs 8,600 crore from these non-core assets during the current fiscal. Meanwhile,......